SCHEMBL569231

SCHEMBL569231

O=C1CCC(C(F)(F)F)CC1

nearest known ligand 0.33

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
TRIM24 O15164 2/20 0.33
TRIM33 Q9UPN9 2/20 0.33
ESR2 Q92731 1/20 0.32
NOS3 P29474 1/20 0.32
NOS1 P29475 1/20 0.32
NOS2 P35228 1/20 0.32
ALDH1A1 P00352 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28247829 0.91 TRIM24 (0.39) TRIM24TRIM33ESR2NOS3NOS1
SCHEMBL29281259 0.84 NOS3 (0.39) NOS3NOS1NOS2
SCHEMBL30342216 0.84
SCHEMBL13766339 0.83 TRIM24 (0.33) TRIM24TRIM33ESR2ALDH1A1
SCHEMBL28185295 0.82 CYP1A2 (0.45) ESR2
SCHEMBL12326589 0.79 CA1 (0.31) TRIM24TRIM33ESR2ALDH1A1
SCHEMBL12326782 0.79 TRIM24 (0.30) TRIM24TRIM33ESR2
SCHEMBL26099934 0.79 TRIM24 (0.30) TRIM24TRIM33ESR2
SCHEMBL14285871 0.75 PIM1 (0.32)
SCHEMBL14421783 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 512 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117645533-B Synthesis method of 4- (trifluoromethyl) cyclohexanone 泰州精英化成医药科技有限公司 2024-10-11 CN claimed
CN-117645533-A Synthesis method of 4- (trifluoromethyl) cyclohexanone 泰州精英化成医药科技有限公司 2024-03-05 CN claimed
CN-113789527-B Electrochemical synthesis method of aromatic amine 四川大学 2023-02-28 CN claimed
CN-113789527-A Electrochemical synthesis method of aromatic amine 四川大学 2021-12-14 CN claimed
EP-4746861-A1 BIS(PHENYLMETHYLENE)CYCLOALKANONES AND THEIR HETEROCYCLIC ANALOGUES AND THEIR USE AS MEDICAMENTS, FOR THE TREATMENT OR PREVENTION OF PROTEINOPATHIES Ustav Organicke Chemie a Biochemie AV CR v.v.i. (CZ) 2026-05-27 EP disclosed
EP-4680336-A1 AMIDE DERIVATIVES FOR INHIBITING NLRP3 AND USES THEREOF Ventus Therapeutics U.S., Inc. (US) 2026-01-21 EP disclosed
US-12528798-B2 Compound for crop protectant LG CHEM, LTD. (KR) 2026-01-20 US disclosed
US-20260007684-A1 AMIDE DERIVATIVES FOR INHIBITING NLRP3 AND USES THEREOF VENTUS THERAPEUTICS U S INC (US) 2026-01-08 US disclosed
EP-4663640-A1 XANTHINE COMPOUND AND USE THEREOF Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CN) 2025-12-17 EP disclosed
US-12441679-B2 Acrylamide-substituted indane compounds and therapeutic use thereof SANOFI (FR) 2025-10-14 US disclosed
EP-4626860-A1 FUSED PYRROLYL-SULFONAMIDE COMPOUNDS ReWind Therapeutics NV (BE) 2025-10-08 EP disclosed
US-12358887-B2 IKAROS Zinc Finger Family degraders and uses thereof GILEAD SCIENCES, INC. (US) 2025-07-15 US disclosed
US-20030078460-A1 Process for producing alpha, alpha-difluorocycloalkane compound MITSUI CHEMICALS, INC. (JP) 2003-04-24 US disclosed
EP-1220841-A2 TRIFLUOROMETHYL-SUBSTITUTED SPIROCYCLIC KETOENOLS Bayer Aktiengesellschaft (DE) 2002-07-10 EP disclosed
EP-0921125-B1 1,3,8-Triazaspiro[4,5]decan-4-on derivatives HOFFMANN LA ROCHE (CH) 2002-01-30 EP disclosed
WO-2001023354-A2 TRIFLUOROMETHYL-SUBSTITUTED SPIROCYCLIC KETOENOLS AND USE THEREOF AS PESTICIDES AND HERBICIDES BAYER AKTIENGESELLSCHAFT (DE) 2001-04-05 WO disclosed
US-6043366-A USEFUL IN TREATING DISORDERS INVOLVING THE ORPHANIN FQ(A SEVENTEEN AMINO ACID LONG PEPTIDE) RECEPTOR. HOFFMAN-LA ROCHE INC. (US) 2000-03-28 US disclosed
CN-1222521-A 1,3,8-triaza-spiro [4,5] decan-4-on derivatives HOFFMANN LA ROCHE (CH) 1999-07-14 CN disclosed
EP-0921125-A1 1,3,8-Triaza-spiro 4,5 decan-4-on derivatives F. HOFFMANN-LA ROCHE AG (CH) 1999-06-09 EP disclosed
WO-1994027972-A1 SUBSTITUTED PYRAZOLINES HAVING INSECTICIDAL AND ACARICIDAL ACTIVITY SCHERING AKTIENGESELLSCHAFT (DE) 1994-12-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12358887-B2 IKAROS Zinc Finger Family degraders and uses thereof IKZF2, IKZF1, IKZF3 TRIM24 241/4885TRIM33 61/4885ESR2 1037/4885
US-12441679-B2 Acrylamide-substituted indane compounds and therapeutic use thereof IDH2, INA, IDH3A TRIM24 4008/4885TRIM33 3535/4885ESR2 955/4885
US-12528798-B2 Compound for crop protectant CBR1, CBR3, GSTO1 TRIM24 2344/4885TRIM33 3028/4885ESR2 2003/4885
US-20260007684-A1 AMIDE DERIVATIVES FOR INHIBITING NLRP3 AND USES THEREOF NOD1, NLRP3, NOD2 TRIM24 3246/4885TRIM33 3148/4885ESR2 1609/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.